Zelira Therapeutics
  • HOME
  • ABOUT
    • OUR COMPANY
    • BOARD
    • ADVISORY BOARD
    • LOCATIONS
    • MEDICAL CANNABIS
      • SCIENCE
      • LEGALISED MARKETS
  • RESEARCH
    • PRODUCT PIPELINE
    • PRECLINICAL
      • PANCREATIC CANCER
      • BREAST CANCER
      • BRAIN CANCER
      • DIABETES RELATED COGNITIVE DECLINE
    • CLINICAL TRIALS
      • AUTISM
      • INSOMNIA
      • CHRONIC PAIN
  • PRODUCTS
    • Doctors
    • Pharmacists
    • Patients
  • INVESTORS
    • ASX ANNOUNCEMENTS
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
    • PRESENTATIONS & VIDEOS
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
    • REPORTS
    • STOCK INFORMATION
    • CORPORATE GOVERNANCE
  • MEDIA
    • VIDEOS & AUDIOS
    • ARTICLES
    • Autism Symposium
  • CONTACT
  • HOME
  • ABOUT
    •         - OUR COMPANY
    •         - BOARD
    •         - ADVISORY BOARD
    •         - LOCATIONS
    •         - MEDICAL CANNABIS
      •                 - SCIENCE
      •                 - LEGALISED MARKETS
  • RESEARCH
    •         - PRODUCT PIPELINE
    •         - PRECLINICAL
      •                 - PANCREATIC CANCER
      •                 - BREAST CANCER
      •                 - BRAIN CANCER
      •                 - DIABETES RELATED COGNITIVE DECLINE
    •         - CLINICAL TRIALS
      •                 - AUTISM
      •                 - INSOMNIA
      •                 - CHRONIC PAIN
  • PRODUCTS
    •         - Doctors
    •         - Pharmacists
    •         - Patients
  • INVESTORS
    •         - ASX ANNOUNCEMENTS
      •                 - 2021
      •                 - 2020
      •                 - 2019
      •                 - 2018
      •                 - 2017
      •                 - 2016
    •         - PRESENTATIONS & VIDEOS
      •                 - 2021
      •                 - 2020
      •                 - 2019
      •                 - 2018
      •                 - 2017
      •                 - 2016
      •                 - 2015
    •         - REPORTS
    •         - STOCK INFORMATION
    •         - CORPORATE GOVERNANCE
  • MEDIA
    •         - VIDEOS & AUDIOS
    •         - ARTICLES
    •         - Autism Symposium
  • CONTACT

Category Archives: articles-2016

Zelda Therapeutics to Test Formulations against Pancreatic Cancer

By Zelira TherapeuticsDecember 20, 2016articles-2016

Zelda Therapeutics to Test Formulations against Pancreatic Cancer

Read More

Company Secretary Appointment

By Zelira TherapeuticsDecember 16, 2016articles-2016

Company Secretary Appointment

Read More

Sleep disorder clinical trials update

By Zelira TherapeuticsDecember 12, 2016articles-2016

Sleep disorder clinical trials update

Read More

Zelda Therapeutics Enters Into Collaboration Agreement with Prestigious Telethon Kids Institute

By Zelira TherapeuticsDecember 5, 2016articles-2016

Zelda Therapeutics Enters Into Collaboration Agreement with Prestigious Telethon Kids Institute  

Read More

Significant Anti-Cancer Effect Observed in Pre-Clinical Studies

By Zelira TherapeuticsNovember 30, 2016articles-2016

Significant Anti-Cancer Effect Observed in Pre-Clinical Studies

Read More

Zelda Expands Intellectual Property Portfolio

By Zelira TherapeuticsNovember 25, 2016articles-2016

Zelda Expands Intellectual Property Portfolio

Read More

Zelda Therapeutics debuts on ASX

By Zelira TherapeuticsNovember 22, 2016articles-2016

Zelda Therapeutics debuts on ASX

Read More

Investor Presentation – Nov 2016

By Zelira TherapeuticsNovember 22, 2016articles-2016

Investor Presentation Nov 2016

Read More

19 Jan 2016 – Q&A Proactive Investors

By Zelira TherapeuticsJanuary 19, 2016articles-2016

19 Jan 2016 – Q&A Proactive Investors  

Read More

SUBSCRIBE

Zelira TherapeuticsFollow

Zelira Therapeutics
30 Jul

Zelira has released its most recent quarterly report for the 2021 financial year.

The Q4 highlights include strong growth on Q3 cash receipts (+38%), accelerating commercialisation and the achievement of significant research milestones.

Read more here:
http://ow.ly/xleR50FGLmK

Twitter 1420955741767208960
Load More...

CONTACT US

    Copyright © Zelira Therapeutics. All rights reserved. | Disclaimer.